-
公开(公告)号:US10947218B2
公开(公告)日:2021-03-16
申请号:US16884666
申请日:2020-05-27
Applicant: NOVARTIS AG
Inventor: Luca Arista , Sreehari Babu , Jianwei Bian , Kai Cui , Michael Patrick Dillon , Rene Lattmann , Jialiang Li , Lv Liao , Dimitrios Lizos , Rita Ramos , Nikolaus Johannes Stiefl , Thomas Ullrich , Peggy Usselmann , Xiaoyang Wang , Liladhar Murlidhar Waykole , Sven Weiler , Yubo Zhang , Yizong Zhou , Tingying Zhu
IPC: A61K31/4427 , C07D405/14 , C07D401/14 , C07D401/10 , C07D401/12 , C07D409/14 , C07D213/82 , C07D411/14 , C07D491/107 , A61P19/00 , C07D417/00 , C07D413/00 , C07D419/00 , A61P19/08 , C07D413/10 , C07D413/12 , C07D413/14 , C07D491/20
Abstract: The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.
-
公开(公告)号:US10710980B2
公开(公告)日:2020-07-14
申请号:US16318250
申请日:2017-07-18
Applicant: NOVARTIS AG
Inventor: Luca Arista , Sreehari Babu , Jianwei Bian , Kai Cui , Michael Patrick Dillon , Rene Lattmann , Jialiang Li , Lv Liao , Dimitrios Lizos , Rita Ramos , Nikolaus Johannes Stiefl , Thomas Ullrich , Peggy Usselmann , Xiaoyang Wang , Liladhar Murlidhar Waykole , Sven Weiler , Yubo Zhang , Yizong Zhou , Tingying Zhu
IPC: C07D405/14 , C07D401/14 , C07D401/10 , C07D401/12 , C07D409/14 , C07D213/82 , C07D411/14 , C07D491/107 , A61P19/00 , C07D417/00 , C07D413/00 , C07D419/00 , A61P19/08 , C07D413/10 , C07D413/12 , C07D413/14 , C07D491/20
Abstract: The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form (I) to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.
-
公开(公告)号:US11021446B2
公开(公告)日:2021-06-01
申请号:US16854762
申请日:2020-04-21
Applicant: NOVARTIS AG
Inventor: Donatella Chianelli , Runyan Li , Valentina Molteni , John Nelson , Jason Thomas Roland , Paul Vincent Rucker , David Charles Tully , Xiaoyang Wang , Liladhar Murlidhar Waykole , Yubo Zhang , Bo Zhou
IPC: C07D231/54 , C07D471/04 , C07D491/052 , A61K31/416 , A61K31/4162 , A61K31/4439 , A61K31/4745 , C07D471/06
Abstract: The present invention relates to compounds of Formula I, a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).
-
-